|
1
|
Sabattini E, Bacci F, Sagramoso C and
Pileri SA: WHO Classification of Tumours of Haematopoietic and
Lymphoid Tissues in 2008: An overview. Pathologica. 102:83–87.
2010.PubMed/NCBI
|
|
2
|
Bernd HW, Ziepert M, Thorns C, Klapper W,
Wacker HH, Hummel M, Stein H, Hansmann ML, Ott G, Rosenwald A, et
al: Loss of HLA-DR expression and immunoblastic morphology predict
adverse outcome in diffuse large B-cell lymphoma - analyses of
cases from two prospective randomized clinical trials.
Haematologica. 94:1569–1580. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alizadeh AA, Eisen MB, Davis RE, Ma C,
Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al:
Distinct types of diffuse large B-cell lymphoma identified by gene
expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosenwald A, Wright G, Leroy K, Yu X,
Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, et
al: Molecular diagnosis of primary mediastinal B cell lymphoma
identifies a clinically favorable subgroup of diffuse large B cell
lymphoma related to Hodgkin lymphoma. J Exp Med. 198:851–862. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Savage KJ, Monti S, Kutok JL, Cattoretti
G, Neuberg D, De Leval L, Kurtin P, Dal Cin P, Ladd C, Feuerhake F,
et al: The molecular signature of mediastinal large B-cell lymphoma
differs from that of other diffuse large B-cell lymphomas and
shares features with classical Hodgkin lymphoma. Blood.
102:3871–3879. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wright G, Tan B, Rosenwald A, Hurt EH,
Wiestner A and Staudt LM: A gene expression-based method to
diagnose clinically distinct subgroups of diffuse large B cell
lymphoma. Proc Natl Acad Sci USA. 100:9991–9996. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shipp MA, Ross KN, Tamayo P, Weng AP,
Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, et
al: Diffuse large B-cell lymphoma outcome prediction by
gene-expression profiling and supervised machine learning. Nat Med.
8:68–74. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Monti S, Savage KJ, Kutok JL, Feuerhake F,
Kurtin P, Mihm M, Wu B, Pasqualucci L, Neuberg D, Aguiar RC, et al:
Molecular profiling of diffuse large B-cell lymphoma identifies
robust subtypes including one characterized by host inflammatory
response. Blood. 105:1851–1861. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rosenwald A, Wright G, Chan WC, Connors
JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland
EB, Giltnane JM, et al: The use of molecular profiling to predict
survival after chemotherapy for diffuse large-B-cell lymphoma. N
Engl J Med. 346:1937–1947. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Copie-Bergman C, Plonquet A, Alonso MA,
Boulland ML, Marquet J, Divine M, Möller P, Leroy K and Gaulard P:
MAL expression in lymphoid cells: Further evidence for MAL as a
distinct molecular marker of primary mediastinal large B-cell
lymphomas. Mod Pathol. 15:1172–1180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lenz G, Wright G, Dave SS, Xiao W, Powell
J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, et al: Stromal gene
signatures in large-B-cell lymphomas. N Engl J Med. 359:2313–2323.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aiken AH and Glastonbury C: Imaging
Hodgkin and non-Hodgkin lymphoma in the head and neck. Radiol Clin
North Am. 46:363–378, ix-x. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Artese L, Di Alberti L, Lombardo M,
Liberatore E and Piattelli A: Head and neck non-Hodgkin's
lymphomas. Eur J Cancer B Oral Oncol. 31B:299–300. 1995. View Article : Google Scholar : PubMed/NCBI
|
